Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKesson
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Wilshire Pharms Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WILSHIRE PHARMS INC, and what generic and branded alternatives to WILSHIRE PHARMS INC drugs are available?

WILSHIRE PHARMS INC has seven approved drugs.



Summary for Wilshire Pharms Inc
US Patents:0
Tradenames:7
Ingredients:7
NDAs:7

Drugs and US Patents for Wilshire Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-004 Dec 17, 2015 AB RX No No   Start Trial   Start Trial
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-001 Dec 17, 2015 AB RX No No   Start Trial   Start Trial
Wilshire Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 205973-002 Dec 17, 2015 AB RX No No   Start Trial   Start Trial
Wilshire Pharms Inc NATEGLINIDE nateglinide TABLET;ORAL 205544-001 Jun 18, 2018 AB RX No No   Start Trial   Start Trial
Wilshire Pharms Inc PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205956-001 Jul 2, 2018 AB RX No No   Start Trial   Start Trial
Wilshire Pharms Inc CARISOPRODOL carisoprodol TABLET;ORAL 205126-001 Jul 8, 2015 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Express Scripts
Harvard Business School
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.